PAR -v- CUV, page-30

Yes, if you do the maths then you get crazy figures, but you gotta temper them.
An example, at least half the countries where these 630 Mil reside wont even get PPS for years after its made commercial in USA/UK/Aus.
The price point will also discount a lot of people out totally. Then you'd have millions that dont even go to a doc and so have no awareness that their lives could be made better. There could be so many other hurdles we havent even come across or can imagine in the next 2 years. Pray that the Phase 3 goes ahead without a hitch.

Im not raining on any parades, Im one of the biggest advocates for this miracle stock and drug, the potential is massive and we are just talking one indication, OA here. All im saying is you cant simply multiply the figures out as you know Im sure being an accountant. It will balance naturally but yes, we are on to a massive potential winner here, it will just take some time for fruition.

The best indicators in my mind is CSL and companies such as SRX and now CUV...these are tiny (although important in their own right, specially for sufferers) compared to what we have. The other exciting thing is to map CUV's progress with ours..dont forget they were $1.50 or so 4 years ago...they are maybe 4 months out from Phase 3 trial results release and what is their price today! We could be at this stage in 18 months from now...

My opinions, DYOR